Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
Information source: Canisius-Wilhelmina Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pancreatitis
Intervention: Erythromycin (Drug); Placebo (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Canisius-Wilhelmina Hospital
Summary
The purpose of this study is to assess the effect of erythromycin on the Rate of Success in
Placement of a Self-propelled Feeding Tube.
Clinical Details
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 48 hours.
Secondary outcome: The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 24 hours.Adverse events using this self-propelled tube
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Aged 18-80 years
- Having pancreatitis
- Require jejunal enteral nutrition
Exclusion Criteria:
- Known impaired peristalsis (critically ill patients, postoperative patients, history
of surgery of the stomach/duodenum)
- Pregnancy
- Hypersensibility to erythromycin
- Cardiac arrhythmias with a prolonged QT-time
- Simultaneous usage of drugs impairing peristalsis
Locations and Contacts
Additional Information
Starting date: October 2004
Last updated: January 21, 2010
|
